Stillora is an independent resource for navigating life with Parkinson’s disease. We publish clear, evidence‑informed material about daily living, caregiving, treatment options, and emerging research, with an emphasis on practical context and respect for lived experience.
Our mission: Stillora offers clear, evidence-informed information on daily living, caregiving, treatment options, and emerging Parkinson’s research. It helps people affected by Parkinson’s consider practical questions with context and care.
Stillora curates and synthesizes information so readers can weigh options and questions without being told what to do. We draw on registries, peer‑reviewed literature, clinical guidelines, and statements from recognized public health authorities to describe what is known, where uncertainty remains, and which decisions benefit from clinical advice. For example, we reference widely used scientific overviews such as the National Institutes of Health resources and topical entries like the Parkinson's disease overview on Wikipedia's Parkinson’s disease article when explaining general background and consensus points.
Our pages are edited to be plainspoken and practical: concise summaries up front, followed by context, and a short note on sources. To help readers assess claims, we include links to primary registries or guideline pages where appropriate, and we note the date when content was last reviewed against the published literature. For research and methods questions we sometimes cite authoritative institutional overviews such as material at NIH or educational resources hosted by university centers.
Stillora covers practical topics across daily living, caregiving, therapies, assistive strategies, and summaries of emerging research. Content is organized by thematic guides and concise explainers, plus deeper feature pieces that gather links and citations for readers who want to follow the primary literature. If you are looking for services or professional evaluation, our Services page explains the editorial distinctions between informational content and professional care listings.
Our editorial work uses a layered approach: we start with primary literature and clinical guidelines, then cross-check registry entries and institutional summaries. When discussing treatment concepts we aim to link to authoritative sources rather than anecdote. In addition to scholarly citations, we refer to institutional guidance such as material from reputable university health centers and government health pages to provide context and to avoid overstating evidence.
To illustrate the care we take with sourcing, many pieces note study type, sample size, and limitations in plain language. For claims about mechanisms or trial outcomes we point readers to standard references such as the National Library of Medicine or academic overviews at major universities rather than relying solely on secondary summaries. See, for example, how professional information is organized at CDC for public health topics.
Because of the evolving nature of research, we include date stamps on substantive rewrites and link inline to the primary reports when possible. Readers will also find in‑text links to original sources or registries when a recommendation, study, or regulatory action is discussed.
Stillora is an independent information resource, not a clinic, medical provider, or licensed treatment center. Our content is not medical or legal advice; it is intended to help people frame questions they may wish to discuss with qualified professionals.
If you would like to return to our main site index and article listings you can use the site index at the top to navigate back to the main collection of guides at the Stillora home index. For information about services and how we distinguish informational content from professional care options see our Services overview.
Readers interested in clinical trials, therapeutic development, and treatment facilities should consult primary registries and regulatory pages; for broader context on research translation consult university research pages such as those hosted by major medical schools (examples include pages at Harvard University and health system guidance hosted by national agencies). For questions about emerging or nonstandard therapies, readers commonly consult dedicated sites; some resources discuss ibogaine and its research context and logistics such as ibogaine4parkinsons and research portals like ibogaineparkinsonsresearch.
Other informational pages sometimes describe how compounds are prepared and where treatment centers operate; those discussions are out of scope for Stillora's editorial direction, but external informational pages such as how is ibogaine made and listings like ibogainecenter in Mexico exist for readers researching topics independently. Readers looking into therapeutic claims often consult topic overviews such as what does ibogaine treat or facility directories like ibogainetreatmentfacility—we link externally to factual pages for context but do not endorse individual treatments.
We prioritize primary literature, clinical guidelines, and institutional summaries. When possible we link directly to registries, peer‑reviewed studies, and government pages so readers can verify claims; we also note limitations and the date of review. For public health and guideline contexts we often point to websites such as the NIH or university overviews to explain general standards.
No. Stillora is an independent information resource and is not a clinic, medical provider, or licensed treatment center. Our pages are informational only and not a substitute for professional medical advice; for services that connect to providers see the editorial distinctions on our Services page.
We include inline citations in articles where appropriate and link to primary registries and academic centers. For deeper dives into trial registries and academic summaries, professional databases and university research pages are commonly used; for an example of the kind of external informational resources that exist on treatment topics, readers sometimes consult sites such as ibogaineparkinsonsresearch and other published project pages, though Stillora does not recommend or endorse specific clinics.